Exploring the role of daidzin as a phytotherapeutic agent in imatinib-resistant CML through in-silico and in-vitro modulation of BCL2 and ABL1
Crossref DOI link: https://doi.org/10.1007/s11696-025-04359-z
Published Online: 2025-09-17
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anusha,
Srivastava, Rashi
Chaudhary, Nazia
Prasad, Rama Chandra
Text and Data Mining valid from 2025-09-17
Version of Record valid from 2025-09-17
Article History
Received: 25 March 2025
Accepted: 31 August 2025
First Online: 17 September 2025